Fundraising Fox
MPM BioImpact
also invests · investor profileBoston, US · Founded 1992 · 63 employees on LinkedIn · 1 known investors
Find your way into MPM BioImpact
Sign up to see every warm intro you have to MPM BioImpact
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MPM BioImpact team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MPM Capital is a venture capital and life sciences investment firm that backs companies in biotech, therapeutics, and healthcare innovation, with a focus on translating scientific research into transformative medicines and treating severe diseases.
Founders & leadership
MPM BioImpact was founded in 1992 by Ansbert Gadicke.
CB
AG
LE
Luke Evnin, Ph.D.Advisor; co-founder of predecessor company MPM CapitalHe co-founded MPM Capital in 1997 and continues to serve as a senior advisor, after seven years as a general partner at Accel Partners; in 2025 he co-founded Vie Ventures, where he is a managing director. He has chaired the Scleroderma Research Foundation since 1999 and Werewolf Therapeutics since 2016, and has run Annulus Cellars since 2020.
CB
Christiana Bardon, M.D., M.B.A.Managing Partner
Investors · 1
Founder mafia
7 people who came through MPM BioImpact went on to found or lead other companies.
Briggs MorrisonExecutive PartnerFounded Crossbow Therapeutics +1Brian GoodmanPrincipalFounded Evelo Biosciences +1Detlev BiniszkiewiczManaging Director/Investment Partner - MPM Innovation FundFounded NextPoint TherapeuticsLuke EvninAdvisor; co-founder of predecessor company MPM CapitalFounded Werewolf TherapeuticsTodd FoleyManaging DirectorFounded Aktis OncologyDavid KoleskyPrincipalFounded Montai TherapeuticsElizabeth StonerEntrepreneur PartnerFounded Semma Therapeutics
Frequently asked questions
- What does MPM BioImpact do?
- MPM Capital is a venture capital and life sciences investment firm that backs companies in biotech, therapeutics, and healthcare innovation, with a focus on translating scientific research into transformative medicines and treating severe diseases.
- Who founded MPM BioImpact?
- MPM BioImpact was founded by Ansbert Gadicke in 1992.
- Who are MPM BioImpact's investors?
- MPM BioImpact's investors include Mission Bay Capital.
- Where is MPM BioImpact headquartered?
- MPM BioImpact is headquartered in Boston, US.